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Background: The aim of this study is to compare clinical outcomes among patients
visited hospital with acute myocardial infarction on weekends and holiday during
absence of available emergency procedure staff, and those visited on weekdays during
working time when available practitioners stay in hospital.
Methods: A total of 13,582 patients diagnosed as AMI from Korean Acute
Myocardial Infarction Registry were enrolled in this study. The patients were divided
into 3 groups; Patients visited hospital on day time (8am to 6pm) of weekdays (group
1, n¼6007), on night time (6pm to 8am) of weekdays (group2, n¼3744), on weekend
or holiday (group 3, n¼3831). Primary end-point was in-hospital mortality. Secondary
end-point was major adverse cardiac events (MACE) at one year.
Results: Patient visited hospital on weekends were less likely to undergo invasive
cardiac procedures than those were admitted on weekdays (In STEMI patients,
primary PCI was done 78.5% of Group1 vs. 73.1% of group2 vs. 69.1% of group3,
p<0.001. In NSTEMI patients, early invasive therapy was done in 49.5% of Group 1
vs. 48.5% of Group2 vs. 40.7% of Group 3, p¼0.000). In-hospital mortality was
observed as 4.9% in Group 1 and 5.3% in Group 2 and 6.0% in Group 3 (p¼0.055).
On comparison with group of patients visited on day time of weekdays and those on
night time of weekday, in-hospital mortality was not different (4.9% vs. 5.3%,
p¼0.319). On comparison with night time on weekdays and weekend or holiday, in-
hospital mortality also was not different (5.3% vs. 6.0%, p¼0.212). However
compared to group of patients visited hospital on day time of weekday, patients visited
on weekend or holiday group had higher in-hospital mortality (4.9% vs. 6.0%,
p¼0.016). MACE for one year occurred 1883 patients (17.2% of group 1 vs 18.5% of
group 2, 19.2% of group3, p¼0.081).
Conclusions: The patients visited hospital on weekend and holiday presented with
AMI had worse clinical outcome than those visited on weekday. However it was not
different between nighttime of weekdays and weekend.
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Background: Hyperglycemia upon admission in patients with ST-segment myocar-
dial infarction (STEMI) is associated with larger infarct size and adverse prognosis.
However, the association of hyperglycemia with area at risk and myocardial salvage
has been insufﬁcient studied. Also, exenatide, a glucagon-like-peptide analogue that is
known to increase the cellular glucose uptake and reduce the level of blood glucose,
has demonstrated to be cardioprotective in STEMI patients undergoing primaryJACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT Abstrpercutaneous coronary intervention (PCI). Thus, the aim of this study was to evaluate
the association of hyperglycemia with area at risk and salvage index in STEMI
patients treated with primary PCI, and assess the interaction between glycemic state
and cardioprotective effect of exenatide.
Methods: In this post-hoc study 210 STEMI patients randomized to exenatide or
placebo were stratiﬁed on the basis of diabetes status and glucose level upon
admission. Cardiovascular magnetic resonance was used to measure area at risk and
ﬁnal infarct size.
Results: One-hundred-and-twenty-ﬁve (60%) patients had normoglycemia and 85
(40%) hyperglycemia. Patients with hyperglycemia had larger area at risk (3311 %
of left ventricle (LV) versus 3011 %LV; p¼0.027) and ﬁnal infarct size (127 %LV
versus 96 %LV; p¼0.024) than patients with normoglycemia The salvage index did
not differ between the groups (0.720.15 versus 0.710.13; p¼0.75), and the infarct
size was not different adjusting for area at risk (p¼0.54). Among patients with nor-
moglycemia treatment with exenatide resulted in increased salvage index of 10%
compared to placebo (p¼0.08), and 14% among patients with hyperglycemia
(p¼0.017), but there was no interaction (p¼0.71).
Conclusions: The presence of hyperglycemia upon admission in STEMI patients is
related to a larger ﬁnal infarct size, which can be explained by an equally larger area at
risk, but not by a reduction in myocardial salvage index. Also, the cardioprotective
effect of exenatide treatment is independent of glucose level upon admission.
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Background: Family history of premature coronary artery disease (FHC) is a well-
known risk factor for the occurrence of CAD. Despite this fact, the clinical proﬁle and
prognosis of patients with FHC presenting with STEMI undergoing primary percu-
taneous coronary intervention (PCI) is unknown.
Methods: A total of 3602 pts presenting with STEMI in the HORIZONS-AMI trial
underwent PCI. Angiographic and ischemic clinical outcomes were assessed at 30
days and 3 years according to FHC.
Results: FHC was present in 1059/3601 pts (29.4%). Pts with FHC were more likely
to be younger (56.7 years vs. 62.1 years, p<0.0001), current smoker (52.4% vs.
43.5%, p<0.0001), have dyslipidemia (47.7% vs. 41.1%, p¼0.0003), were less likely
to have diabetes (14.1% vs. 17.5%, p¼0.01) or peripheral vascular disease (3.1% vs.
5.0%, p¼0.01), and had shorter time for symptoms to presentation time (100 minutes
vs. 120 minutes, p¼0.002). There was no difference in the severity of extend of CAD
at baseline according to FHC. Pts with FHC had better angiographic results after PCI,
with higher rates of TIMI 3 ﬂow (93.8% vs. 90.6%, p¼0.002), myocardial blush grade
2 or 3 (83.2% vs. 78.0% p¼0.0008), less slow reﬂow (0.8% vs. 2.1%, p¼0.006) and
abrupt closure (0.1% vs. 0.6%, p¼0.05). The unadjusted 30-day and 3-year mortality
rates were lower in pts with FHC compared to no FHC (1.8% vs. 3.0%, p¼0.046 and
4.8% vs. 7.7%, p¼0.002, respectively), while other ischemic endpoints were similar
between the two groups. By multivariable analysis, the presence of FHC was not an
independent predictor of death at 3 years (HR [95%C] ¼ 0.87 [0.60, 1.25], p¼0.45).
Conclusions: Patients with STEMI in whom FHC was present were younger and
(surprisingly) more often smokers. Despite better acute angiographic results after PCI
in patients with compared to without PCI, the presence of FHC was not an inde-
pendent predictor of long-term death or event-free survival.acts/POSTER/STEMI/NSTEMI/ACS B77
